Christopher David Taves

Christopher David Taves is a declared insider of MediPharm Labs Corp., with filings sourced from SEDI. Over a trading history stretching from 19 May 2021 to 9 June 2026, the count stands at 13 filings.

In open-market terms, that means 5 purchases worth €206k on one side and 1 sale worth €8,219 on the other. Taken together, the purchases exceed the sales by €198k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 7 option exercises. In 2026 alone, the filings show no purchases and 1 sale.

In size, the median ticket on the buying side is €33k. Across 5 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The record was last updated on 12 June 2026 with an open-market sale (€8,219) in MediPharm Labs Corp. The last insider purchase was made public on 27 May 2021, 1,976 days ago. The median gap between a trade and its publication by SEDI is 3 days. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.